deltatrials
Completed OBSERVATIONAL NCT04355871

Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain (COVID19@Spain)

Characteristics and Predictors of Death Among Hospitalized Patients With COVID-19 in Spain

Sponsor: Fundacion SEIMC-GESIDA

Conditions Covid19
Updated 7 times since 2020 Last updated: Jun 29, 2023 Started: Mar 18, 2020 Primary completion: Apr 15, 2020 Completion: Apr 17, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Covid19 and is currently completed. Fundacion SEIMC-GESIDA leads this study, which shows 7 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~May 2020 – ~Jun 2020 · 31 days · monthly snapshotActive Not Recruiting~Jun 2020 – ~Jan 2021 · 7 months · monthly snapshotCompleted~Jan 2021 – ~Aug 2023 · 31 months · monthly snapshotCompleted~Aug 2023 – ~Jul 2024 · 11 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Aug 2023 — Jul 2024 [monthly]

    Completed

  5. Jan 2021 — Aug 2023 [monthly]

    Completed

Show 2 earlier versions
  1. Jun 2020 — Jan 2021 [monthly]

    Completed

    Status: Active Not RecruitingCompleted

  2. May 2020 — Jun 2020 [monthly]

    Active Not Recruiting

    First recorded

Mar 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fundacion SEIMC-GESIDA
Data source: Fundacion SEIMC-GESIDA

For direct contact, visit the study record on ClinicalTrials.gov .